Showing results (221-230 of 240) with videos related to

Sort By:
Pageof 24
HIV Medicine|January 29, 2019
Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohortJ M Llibre, A Montoliu, J M Miró, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|October 16, 2012
Multifunctional targets of dietary polyphenols in disease: a case for the chemokine network and energy metabolismJ Joven, A Rull, E Rodriguez-Gallego, et al.
HIV Medicine|June 4, 2009
Impact of prior pneumococcal vaccination on clinical outcomes in HIV-infected adult patients hospitalized with invasive pneumococcal diseaseA Imaz, V Falcó, M Peñaranda, et al.
Pediatric Emergency Care|January 14, 2026
Screening Pediatric Trauma Patients for Blunt Cerebrovascular Injury Using the McGovern Score: A Retrospective Cohort StudyReyna G Osorio, Adam B Johnson, Lucas P Neff, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 4, 2010
Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapyJ Cobo, L Garcia San Miguel, G Euba, et al.
HIV Medicine|November 23, 2012
Metformin: a cheap and well-tolerated drug that provides benefits for viral infectionsJ Joven, J A Menéndez, L Fernandez-Sender, et al.
Circulation|April 1, 2009
Kidney androgen-regulated protein transgenic mice show hypertension and renal alterations mediated by oxidative stressO Tornavaca, G Pascual, M L Barreiro, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|May 12, 2009
Agreement in the interpretation of magnetic resonance images of the lumbar spineF M Kovacs, A Royuela, T S Jensen, et al.
HIV Medicine|December 10, 2013
Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapyG Sampériz, D Guerrero, M López, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2016
Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)J A Perez-Molina, R Rubio, A Rivero, et al.
Pageof 24